Testing effectiveness (Phase 2)UnknownNCT00559221
What this trial is testing
FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML
Who this might be right for
Acute Myeloid Leukemia
Cooperative Study Group A for Hematology 37